Advanced Lung Cancer Inflammation Index (ALI)

Advanced Lung Cancer Inflammation Index (ALI) - a deterministic tool in Sophie Well's Clinical Scoring & Risk group.

Open the Advanced Lung Cancer Inflammation Index (ALI) → Runs in your browser. No signup, no tracking.

What this is

Advanced Lung Cancer Inflammation Index (ALI) is one of 230 deterministic tools in Sophie Well's Clinical Scoring & Risk group. Advanced Lung Cancer Inflammation Index (ALI) - a deterministic tool in Sophie Well's Clinical Scoring & Risk group.

When to use it

Use this tool when you need a quick, citable reference. Every calculation runs entirely in your browser - no inputs leave your device, no account is required, no AI is involved. The site enforces a strict Content Security Policy and ships no analytics or third-party CDN.

References

Jafri SH, Shi R, Mills G. Advanced lung cancer inflammation index (ALI) at diagnosis is a prognostic marker in patients with metastatic non-small cell lung cancer (NSCLC): a retrospective review. BMC Cancer. 2013;13:158. Read the source ↗

Worked example: Advanced Lung Cancer Inflammation Index 33.3 — interpretation is context-dependent (a lower value is less favorable).

Sophie Well is a reference and educational tool. Not medical, legal, or financial advice. Does not replace clinician judgment, professional billing review, or legal counsel.

Built by Clay Good. Source on GitHub.